MENU
GET LISTED
GET LISTED
SHOW ALLPOPULAR CATEGORIES

Compare BigSIS vs Vivantio

SCORES FEATURES PRICING PRICING MODEL INTEGRATIONS

What is better BigSIS or Vivantio? To make sure you acquire the most useful and productive CRM Software for your enterprise, you need to compare products available on the market. For instance, here you can match BigSIS’s overall score of 8.0 against Vivantio’s score of 8.4. You can even review their general user satisfaction: BigSIS (N/A%) vs. Vivantio (93%).

Moreover, you can assess their strengths and weaknesses feature by feature, including their offered terms and costs. By comparing products you are improving your chances to select the right software for your budget. It’s clear you have to know your particular requirements to realize which service addresses those needs.

As of now, the most significant services in our Online CRM Software category are: Freshsales, HubSpot Smart CRM, Salesforce CRM.

In the event you are still having doubts about which solution will work best in your case it may be a good idea to examine each service’s social metrics. These metrics are frequently a sign of how popular every service is and how wide is its online presence. For instance, in case of Facebook BigSIS has 247 likes on their official profile while Vivantio profile is liked by 0 people.

Page last modified

Why is FinancesOnline free? Why is FinancesOnline free?

FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.